Crossmark

Cause-specific mortality following sustained virologic response in hepatitis C patients treated with direct-acting antivirals: a standardized mortality ratio analysis

Crossref DOI link: https://doi.org/10.1038/s41598-025-29972-6

Published Online: 2025-11-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mawatari, Seiichi

Tanoue, Shiroh

Kumagai, Kotaro

Oda, Kohei

Toyodome, Ai

Sakae, Haruka

Fujisaki, Kunio

Inada, Yukiko

Uto, Hirofumi

Saisyoji, Akiko

Hiramine, Yasunari

Tabu, Kazuaki

Ijuin, Sho

Hori, Takeshi

Tamai, Tsutomu

Moriuchi, Akihiro

Kanmura, Shuji

Ido, Akio
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP25fk0210174)
License Information

Text and Data Mining valid from 2025-11-27

Version of Record valid from 2025-12-30
More Information

Article History

Received: 26 September 2025

Accepted: 20 November 2025

First Online: 27 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below